A Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis Who Are Direct Acting Antiviral Treatment-naive
Clinical trial NCT02993250 · COMPLETED
Trial details
- NCT number
- NCT02993250
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-21
- Primary completion
- 2018-05-07
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.